TP53 mutation is one of the most frequent alterations in human tumors [28], and its role in metabolic reprogramming has been elucidated in several cancers, including hepatocellular carcinoma [29], pancreatic [30], ovarian [31], head and neck [32], and breast cancer [33,34]. Here, TP53 is linked to hepatocellular carcinoma.